Clinical Trials

    Showing 1 - 2 of 2 Parkinson's Disease

    A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) (REGENERATE-PD)

    Status: Enrolling

    Investigator: William Ondo

    Study Coordinator: Daniel Arnaud Dominguez

    Phone: 346.356.3635

    The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered to the putamen in subjects with moderate Parkinson's Disease.... Read more >

    A Study of Biological Markers for the Nervous and Immune Systems and Free Radical Mediated Processes in Amyotrophic Lateral Sclerosis (ALS)

    Status: Enrolling

    Investigator: Stanley Appel

    Study Coordinator: KaDeesia Brown

    Phone: 713.441.9120

    The purpose of this protocol is to develop and maintain a biospecimen bank comprised of blood, urine, CSF collected during diagnostic evaluations, tissue from biopsies and autopsies collected from patients with neurological disease and non-neurolog... Read more >